When Research Priorities Move Backward, Communities Pay the Price

A Question of Balance

Dr. Pham is clear that research into the causes of autism has scientific merit.

“There is legitimate reason to try to better understand the causes of autism,” she explains. “There is also legitimate reason to explore clinical interventions that can improve life outcomes.”

But she cautions that a singular emphasis on “cause and cure” risks narrowing how autism is understood.

“Autistic people exhibit widely varying abilities and challenges,” she notes. “‘Treatment’ for autistic traits and behaviors easily crosses into a posture that reads like trying to erase what is special about a given person.”

She shared how a counselor once explained to her son that his profound challenges were inseparable from his profound talents. “That is how his brain is wired,” she says. “There is little acknowledgement in ‘cause and cure’ research of what might happen to a person’s special-ness when we try to eliminate traits that are less convenient.”

Most autistic people, she emphasizes, “don’t want to be pathologized or cured. They want to be understood and supported. They want autonomy and respect.”

Dr. Pham also points out that federal investment has already heavily favored biomedical inquiry over the past several decades.

“We have already invested several decades of research into ‘cause and cure,’ at the expense of research into interventions and policies that improve life outcomes,” she says. “Doing so now feels like a throwback to 20 years ago, and a reversion to a sole focus on the medical model of disability.”

The Stakes for 16 Million Americans

An estimated 16–20 million Americans live with intellectual and developmental disabilities, representing roughly 3–5% of the U.S. population. IDD includes autism, cerebral palsy, Down syndrome, intellectual disability, ADHD, and a range of other developmental conditions.

Health disparities remain substantial.

People with IDD:

• Have higher rates of chronic conditions such as diabetes and heart disease
• Experience significantly elevated maternal mortality
• Are less likely to receive preventive care and cancer screenings
• Face suicide rates three times higher among people with intellectual disability and six times higher among autistic individuals
• Are more likely to experience social isolation and limited emotional supports

Racial disparities compound these inequities. While research shows that racial gaps in autism diagnosis have narrowed in recent years, Black and Hispanic autistic individuals continue to face greater barriers to accessing timely services and coordinated care. Autistic people of color report worse physical and mental health outcomes and higher rates of chronic conditions than their white peers.

Against this backdrop, Dr. Pham warns that deprioritizing health services research could widen these gaps.

“Not investing in health services research hampers clinicians’ ability to offer meaningful supports, policymakers’ ability to make rational investments in infrastructure, and caregivers’ ability to get the supports they need,” she says.

Why This Affects Everyone

The implications extend well beyond the autism community.

“When we design healthcare solutions for people with IDD, it turns out those tools make healthcare better for a lot of other people,” Dr. Pham explains. Tools developed to support autistic patients can improve care for people with dementia, limited English proficiency, or complex medical needs.

She points to a familiar example: curb cuts were created for wheelchair users, but they now benefit parents with strollers, travelers with luggage, and older adults.

Designing for people with IDD often strengthens the entire system.

Dr. Pham also emphasizes the importance of protecting Home- and Community-Based Services (HCBS), which allow people with disabilities to live outside institutional settings. Fiscal or policy shifts that undermine these supports would have immediate consequences for families and communities.

A Call for Philanthropic Leadership

Moments like this clarify philanthropy’s role.

If federal advisory bodies narrow their focus, philanthropy can widen it.
If public funding tilts toward biomedical inquiry at the expense of lived experience, philanthropy can invest in health services research, disability-led leadership, and the policy infrastructure that protects autonomy and access.
If narratives shift toward pathology, philanthropy can amplify strengths-based frameworks and center autistic voices.

This is not about opposing scientific inquiry. It is about balance. It is about ensuring that one paradigm does not crowd out the investments that make daily life safer, more accessible, and more dignified.

The United States is home to an estimated 16–20 million people with intellectual and developmental disabilities. Their health outcomes depend not only on laboratory discoveries, but on whether we fund the systems that allow them to participate fully in community life.

When research priorities move backward, communities feel it first.

Philanthropy has both an opportunity and a responsibility to lean in now: to defend the social model of disability, to protect home- and community-based services, to fund research that improves real-world outcomes, and to design health systems that work for everyone because they were built for those most often excluded.

Designing for the edges does not weaken the system.
It strengthens it.